REBOOT

Welcome to the Brand page for “REBOOT”, which is offered here for Providing a website featuring technology that enables physicians, pharmacists, and patients to search databases for patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to maintain a medical registry containing information regarding patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to engage in interactive record keeping relating to patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to distribute information on the safe and effective use of oxazaphosphorine pharmaceuticals, and to set reminders and send notices to physicians and pharmacists for the purpose of minimizing drug interactions;.

Its status is currently believed to be active. Its class is unavailable. “REBOOT” is believed to be currently owned by “Accentia Biopharmaceuticals, Inc.”